A Study to Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(3 sites)

Australia

Nucleus Network Pty Ltd, Geelong, Victoria

Nucleus Network, Melbourne, Victoria

Nucleus Network Pty Ltd, Melbourne